Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Phospholipid nanosomes.

Castor TP.

Curr Drug Deliv. 2005 Oct;2(4):329-40. Review.

PMID:
16305436
[PubMed - indexed for MEDLINE]
2.

Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.

Koo OM, Rubinstein I, Onyuksel H.

Nanomedicine. 2005 Mar;1(1):77-84. Erratum in: Nanomedicine. 2005 Jun;1(2):192.

PMID:
17292061
[PubMed - indexed for MEDLINE]
3.

A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.

Han M, He CX, Fang QL, Yang XC, Diao YY, Xu DH, He QJ, Hu YZ, Liang WQ, Yang B, Gao JQ.

Pharm Res. 2009 Apr;26(4):926-35. doi: 10.1007/s11095-008-9795-9. Epub 2008 Dec 2.

PMID:
19048358
[PubMed - indexed for MEDLINE]
4.

Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.

Joguparthi V, Xiang TX, Anderson BD.

J Pharm Sci. 2008 Jan;97(1):400-20.

PMID:
17879989
[PubMed - indexed for MEDLINE]
5.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V.

Eur J Pharm Biopharm. 2009 Oct;73(2):230-8. doi: 10.1016/j.ejpb.2009.06.015. Epub 2009 Jul 3.

PMID:
19577643
[PubMed - indexed for MEDLINE]
6.

Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.

Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK.

Pharmazie. 2009 May;64(5):301-10.

PMID:
19530440
[PubMed - indexed for MEDLINE]
7.

Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process.

Park JH, Chi SC, Lee WS, Lee WM, Koo YB, Yong CS, Choi HG, Woo JS.

Arch Pharm Res. 2009 Jan;32(1):139-48. doi: 10.1007/s12272-009-1128-y. Epub 2009 Jan 29.

PMID:
19183887
[PubMed - indexed for MEDLINE]
8.

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.

Vassileva V, Grant J, De Souza R, Allen C, Piquette-Miller M.

Cancer Chemother Pharmacol. 2007 Nov;60(6):907-14. Epub 2007 Mar 21.

PMID:
17375303
[PubMed - indexed for MEDLINE]
9.

Preparation and evaluation of paclitaxel-containing liposomes.

Holvoet C, Vander Heyden Y, Lories G, Plaizier-Vercammen J.

Pharmazie. 2007 Feb;62(2):126-32.

PMID:
17341033
[PubMed - indexed for MEDLINE]
10.

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.

Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.

J Control Release. 2008 May 8;127(3):208-18. doi: 10.1016/j.jconrel.2008.01.013. Epub 2008 Feb 7.

PMID:
18336946
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.

Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.

Biomaterials. 2008 Mar;29(9):1233-41.

PMID:
18093646
[PubMed - indexed for MEDLINE]
12.

Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.

Mugabe C, Hadaschik BA, Kainthan RK, Brooks DE, So AI, Gleave ME, Burt HM.

BJU Int. 2009 Apr;103(7):978-86. doi: 10.1111/j.1464-410X.2008.08132.x. Epub 2008 Oct 31.

PMID:
19007363
[PubMed - indexed for MEDLINE]
13.

The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.

Jackson JK, Hung T, Letchford K, Burt HM.

Int J Pharm. 2007 Sep 5;342(1-2):6-17. Epub 2007 May 3.

PMID:
17555895
[PubMed - indexed for MEDLINE]
14.

Ionically fixed polymeric nanoparticles as a novel drug carrier.

Lee SW, Chang DH, Shim MS, Kim BO, Kim SO, Seo MH.

Pharm Res. 2007 Aug;24(8):1508-16. Epub 2007 Mar 23.

PMID:
17380262
[PubMed - indexed for MEDLINE]
15.

Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.

He X, Ma J, Mercado AE, Xu W, Jabbari E.

Pharm Res. 2008 Jul;25(7):1552-62. doi: 10.1007/s11095-007-9513-z. Epub 2008 Jan 15.

PMID:
18196205
[PubMed - indexed for MEDLINE]
16.

RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.

Zhao H, Wang JC, Sun QS, Luo CL, Zhang Q.

J Drug Target. 2009 Jan;17(1):10-8. doi: 10.1080/10611860802368966 .

PMID:
19016068
[PubMed - indexed for MEDLINE]
17.

Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.

Lu JL, Wang JC, Zhao SX, Liu XY, Zhao H, Zhang X, Zhou SF, Zhang Q.

Eur J Pharm Biopharm. 2008 Aug;69(3):899-907. doi: 10.1016/j.ejpb.2008.02.023. Epub 2008 Mar 8.

PMID:
18434109
[PubMed - indexed for MEDLINE]
18.

Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.

Miyata R, Ueda M, Jinno H, Konno T, Ishihara K, Ando N, Kitagawa Y.

Int J Cancer. 2009 May 15;124(10):2460-7. doi: 10.1002/ijc.24227.

PMID:
19173297
[PubMed - indexed for MEDLINE]
19.
20.

Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.

Lee LY, Wang CH, Smith KA.

J Control Release. 2008 Jan 22;125(2):96-106. Epub 2007 Oct 13.

PMID:
18054107
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk